Bahram Bodaghi - research works

Mean preoperative IOP was 25.5 ± 7.7 mmHg with 3.5 ± 1.1 medications.

Complete success decreased from 28% at 6 months to 12.5% at 24 months, while qualified success increased from 72% to 87.5%.

Visual field mean deviation remained stable (mean change -0.79 dB; p = 0.21).

Surgical reintervention was required in 2 eyes (8%).

Etiologically, non-infectious uveitis predominated (44.9%, 95% CI: 39.4-50.5%), followed by idiopathic (34.3%, 95% CI: 29.9-39.0%) and infectious uveitis (23.0%, 95% CI: 20.6-25.5%).

All pooled estimates showed substantial heterogeneity (I 2 > 90%).

Treatment patterns and complication rates were inconsistently reported and are therefore summarized descriptively.

At a threshold of 0, the ISOLD score yielded overall sensitivity of 86.8%, specificity of 98.6%, PPV of 94.3%, and NPV of 96.6% across all 183 samples.

The IL-10/IL-6 ratio at a threshold of 0.6 in AH (n=150) demonstrated sensitivity 77.8%, specificity 93.9%, PPV 63.6% and NPV 96.9%; at a threshold of 1 in vitreous (n=27), sensitivity, specificity, PPV, and NPV were 80%, 100%, 100%, and 63.6%, respectively.